Results
Interview with 'unicorn'-CEO Felix Van De Maele
Founder of VUB spin-off Collibra Felix Van De Maele was a guest in the studio at BRUZZ. He tells that 10 years ago the Brussels Region was the only investor that believed in his idea and that is why Brussels was and still is a very important stakeholder for the company.
Read more
eTheRNA recruited first patient for mRNA immunotherapy
VUB spin-off eTheRNA announces the recruitment of the first patient for a collaborative TriMix-BRE study to investigate the effect of the TriMix product as neo-adjuvant treatment (treatment before planned surgery) for breast cancer patients.
Read more
Collibra first Belgian startup valued at $1 billion
CapitalG, an investment arm of Google parent Alphabet, has led a $100 million funding round in the data technology spin-off Collibra.
Read more
VUB innovative technologies at knowledge for growth 2019
Together with TTO Flanders, a joint initiative of the tech offices of 5 the Flemish universities, VUB is represented at thé life sciences conference and exhibit in Ghent today, where the 5 universities demonstrate and pitch applied and strategic research.
VUB sho...
Read more
Successful closing of the VUB BI³ Fund
Founded in 2002 and closed earlier this year, BI³ Fund invested in 8 spin-offs of the Vrije Universiteit Brussel. One of them was Collibra, the first Belgian unicorn. Purpose was to invest in an early stage when other investors were not interested to take the risk.
Read more
Programming language DISCOPAR gives boost to citizen science
Under the guidance of Prof. Wolfgang De Meuter of the Software Languages Lab at the VUB, dr.
Read more
Finding financing and investment
Read more
Camel-IDS appoints new Chief Medical Officer
VUB spin-off Camel-IDS announced the appointment of Ruggero Della Bitta MD, PhD, as Chief Medical Officer.
Read the press release.
Read more
VUB builds dry room for battery developments
The MOBI research group of the Vrije Universiteit Brussel is investing in a high-tech pilot line for the development and production of new battery technologies for electric vehicles.
Read more
Fertiga closes first financing round
VUB spin-off Fertiga announces the closure of its first financing round together with Novalis Biotech Incubation and international private investors.
Its product, the Corona Test was initially developed by the research team of Prof. Dr.
Read more